1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with natriuretic peptide, c-type in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (natriuretic peptide, c-type) | Trials (natriuretic peptide, c-type) | Recent Studies (post-2010) (natriuretic peptide, c-type) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 1,413 | 31 | 477 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, MZ; Gao, Z; Liu, XH; Pei, LN; Zhang, H; Zhu, J | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and natriuretic peptide, c-type
| Article | Year |
|---|---|
Clinical efficacy of mouse nerve growth factor plus nimodipine in neonatal intracranial hemorrhage and its effect on plasma PAF, CNP, MMP-2, and neurological function.
Topics: Animals; Humans; Infant, Newborn; Infant, Newborn, Diseases; Injections, Intramuscular; Intracranial Hemorrhages; Matrix Metalloproteinase 2; Mice; Natriuretic Peptide, C-Type; Nerve Growth Factor; Nimodipine; Platelet Activating Factor; Retrospective Studies | 2021 |